Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.45 |
| ▸ | CES1 | P23141 | 1/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.44 |
| ▸ | DRD3 | P35462 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.44 |
| ▸ | EDNRB | P24530 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | MC4R | P32245 | 1/20 | 0.44 |
| ▸ | MC3R | P41968 | 1/20 | 0.44 |
| ▸ | DRD2 | P14416 | 1/20 | 0.44 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.44 |
| ▸ | SRC | P12931 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6359024 | 1.00 | EPHX1 (0.66) | EPHX1CYP2C19CYP2D6CYP1A2PKM | |
| SCHEMBL16881947 | 1.00 | EPHX1 (0.66) | EPHX1CYP2C19CYP2D6CYP1A2PKM | |
| SCHEMBL27689551 | 1.00 | EPHX1 (0.66) | EPHX1CYP2C19CYP2D6CYP1A2PKM | |
| Hydrochloric Acid SCHEMBL222654 | 0.98 | EPHX1 (0.63) | EPHX1CYP2C19CYP2D6CYP1A2PKM | |
| Bromide SCHEMBL221448 | 0.98 | EPHX1 (0.63) | EPHX1CYP2C19CYP2D6CYP1A2PKM | |
| Lactic Acid SCHEMBL27998199 | 0.89 | EPHX1 (0.54) | EPHX1CYP2C19CYP2D6CYP1A2LMNA | |
| Ethylbenzene SCHEMBL27718807 | 0.88 | EPHX1 (0.62) | EPHX1CYP2C19CYP1A2LMNAMEN1 | |
| Paraben SCHEMBL10942097 | 0.85 | LMNA (0.53) | EPHX1CES2CES1LMNAMEN1 | |
| SCHEMBL7906110 | 0.83 | EPHX1 (0.61) | EPHX1CYP2C19CYP2D6CYP1A2PKM | |
| SCHEMBL7909103 | 0.83 | EPHX1 (0.61) | EPHX1CYP2C19CYP2D6CYP1A2PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 14765 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137558-A1 | OPHTHALMIC DEVICE | Able Tx Ltd. (IL) | 2026-05-21 | — | — | US | claimed |
| US-12629360-B2 | Ophthalmic composition | Sydnexis, Inc. (US) | 2026-05-19 | — | — | US | claimed |
| WO-2026100654-A1 | NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD | 株式会社インファーマシア | 2026-05-15 | — | — | WO | claimed |
| EP-4736841-A1 | A MUCOADHESIVE LAYER FOR BUCCAL ADMINISTRATION OF AN ACTIVE PHARMACEUTICAL INGREDIENT | IQ medical GmbH (DE) | 2026-05-06 | — | — | EP | claimed |
| EP-4732755-A2 | A SYSTEM FOR AND METHOD OF MONITORING EYE MEDICATION | Ocuvation Limited (IE) | 2026-04-29 | — | — | EP | claimed |
| US-20260108150-A1 | System For And Method Of Monitoring Eye Medication | OCUVATION LTD (IE) | 2026-04-23 | — | — | US | claimed |
| EP-4724079-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION | Stealth BioTherapeutics Inc. (US) | 2026-04-15 | — | — | EP | claimed |
| EP-4724839-A2 | CONTACT LENSES INCLUDING MEDICAMENTS AND METHODS OF MAKING AND USING SAME INCLUDING SLOW RELEASE OF GLAUCOMA TREATING DRUGS AND COMFORT ENHANCING DRUGS | Mediprint Ophthalmics Inc. (US) | 2026-04-15 | — | — | EP | claimed |
| EP-4724049-A1 | MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF | Catalent Ontario Limited (CA) | 2026-04-15 | — | — | EP | claimed |
| US-20260090984-A1 | CONTACT LENSES INCLUDING MEDICAMENTS AND METHODS OF MAKING AND USING SAME INCLUDING SLOW RELEASE OF GLAUCOMA TREATING DRUGS AND COMFORT ENHANCING DRUGS | MEDIPRINT OPHTHALMICS INC. (US) | 2026-04-02 | — | — | US | claimed |
| EP-0224352-B1 | OCULAR TREATMENT | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1990-08-29 | — | — | EP | claimed |
| US-4952212-A | Ocular treatment | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1990-08-28 | — | — | US | claimed |
| EP-0224352-A1 | Ocular treatment | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1987-06-03 | — | — | EP | claimed |
| EP-0126684-A2 | Drug delivery system utilizing thermosetting gels | MERCK & CO. INC. (US) | 1984-11-28 | — | — | EP | claimed |
| US-4478936-A | In vitro enzymatic process for producing glucuronides | REPLIGEN CORPORATION (US) | 1984-10-23 | — | — | US | claimed |
| US-4474751-A | SUSTAINED RELEASE USING AN ALKYLENEDIAMINE-MODIFIED ETHYLENE OXIDE-PROPYLENE OXIDE COPOLYMER | MERCK & CO., INC. (US) | 1984-10-02 | — | — | US | claimed |
| WO-1983004263-A1 | GLUCURONIDES AND METHODS FOR THEIR PREPARATION | REPLIGEN CORPORATION (US) | 1983-12-08 | — | — | WO | claimed |
| EP-0095362-A1 | Glucuronides and methods for their preparation | REPLIGEN CORPORATION (US) | 1983-11-30 | — | — | EP | claimed |
| US-4186184-A | Selective administration of drug with ocular therapeutic system | ALZA CORPORATION (US) | 1980-01-29 | — | — | US | claimed |
| US-4014335-A | Ocular drug delivery device | ALZA CORPORATION (US) | 1977-03-29 | — | — | US | claimed |